XT
KRON

XTX Topco’s Kronos Bio KRON Stock Holding History

XTX Topco’s Portfolio KRON Stock Details KRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-43,117
Closed -$41K – 2756
2024
Q4 		$41K Buy
43,117
+1,651
+4% +$1.56K ﹤0.01% 1932
2024
Q3 		$41.5K Sell
41,466
-8,445
-17% -$9.35K ﹤0.01% 1721
2024
Q2 		$61.9K Buy
49,911
+9,096
+22% +$9.26K 0.01% 1484
2024
Q1 		$53.1K Buy
40,815
+8,783
+27% +$10K 0.01% 1463
2023
Q4 		$40K Buy
32,032
+10,818
+51% +$12K 0.01% 1273
2023
Q3 		$27.6K Sell
21,214
-566
-3% -$914 ﹤0.01% 1345
2023
Q2 		$37.5K Buy
+21,780
New +$34.6K 0.01% 1275
2023
Q1 		– Sell
-25,184
Closed -$40.8K – 1477
2022
Q4 		$40.8K Sell
25,184
-75,469
-75% -$174K 0.01% 1054
2022
Q3 		$337K Buy
100,653
+38,134
+61% +$172K 0.08% 430
2022
Q2 		$228K Buy
+62,519
New +$283K 0.09% 412

Other funds holding KRON

VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCIG
Partners Capital Investment Group Boston, Massachusetts $2.83B AUM 20.31% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
WCM
Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

XTX Topco's KRON Position: Q1 2025 in Review

XTX Topco sold out of Kronos Bio (KRON) in Q1 2025, closing a stake of 43,117 shares — an estimated $41K sold.

XTX Topco first reported a position in KRON in Q2 2022 and held it in 10 quarters. The position peaked at $337K in Q3 2022. 47 funds tracked by Wall St. Rank hold KRON as of Q1 2025.

  • XTX Topco reported no remaining Kronos Bio position as of Q1 2025 after selling out during the quarter.
  • XTX Topco sold 43,117 Kronos Bio shares in Q1 2025, an estimated $41K.
  • XTX Topco first reported a position in Kronos Bio in Q2 2022 and held it in 10 quarters.
  • XTX Topco's Kronos Bio position peaked at $337K in Q3 2022.
  • 47 funds tracked by Wall St. Rank held Kronos Bio as of Q1 2025.

Based on XTX Topco's 13F filing for Q1 2025, filed 8 May 2025.